TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
HUM

Humana Inc

Healthcare · Healthcare Plans

384.50$ -0.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Humana Inc (HUM). It shows which part of the business is growing — and which one is holding it back.

Operating metrics

Operating metrics are the figures a company uses to measure its own business — customer counts, stores, deliveries or the churn rate. None of them appear in the financial statements, and they often explain earlier than revenue does why revenue is moving.

Operating metrics — HUM
Metric Q2 2025 Q3 2025 Q1 2026 Q2 2026
Total Medical Membership 14.8M 15.0M 17.7M 17.9M +20.7%
Total Medicare members 8.2M 8.3M 11.0M 11.1M +35.3%
Individual Medicare Advantage members 5.2M 5.2M 6.4M 6.5M +23.4%
Total Specialty Membership 4.7M 4.7M 4.9M 4.9M +4.2%
Military services members 4.6M 4.6M 4.6M 4.6M +0.9%
Members in value-based relationships 3.5M 3.6M 4.1M 4.1M +16.3%
Medicare stand-alone PDP members 2.4M 2.4M 3.9M 3.9M +62.6%
State-based contracts and other members 1.6M 1.7M 1.6M 1.6M +1.3%
D-SNP members 786,000 765,800 945,100 959,900 +22.1%
Group Medicare Advantage members 570,000 569,800 729,200 727,200 +27.6%
Medicare Supplement members 444,100 474,700 536,800 551,500 +24.2%

These metrics are not part of the financial statements; they sit in the narrative text of the filings. We read them out of the SEC filings using artificial intelligence and check every single figure against the original passage in the report; anything that is not found there verbatim is discarded. Source: SEC EDGAR (annual and quarterly reports, 10-K/10-Q).

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?